CMMB 財務： Chemomab Therapeutics Ltd AI 分析

首頁

股票

CMMB

CMMB 財務

Chemomab Therapeutics Ltd

$1.48

-1.65%

$-0.02

截至今日：Feb 17, 15:30:16 GMT-5

概觀預測收益股利財務狀況

關鍵數據

前收市價

$1.51

開盤價

$1.55

當日範圍

$1.46 - $1.55

52週區間

$1.42 - $8.25

交易量

67.1K

平均成交量

119.0K

每股盈餘 (TTM)

-0.07

股息收益率

市值

$28.0M

什麼是 CMMB？

Chemomab Therapeutics Ltd. is a clinical-stage biotech company, which engages in the provision of therapeutics for conditions with unmet need that involve Inflammation and fibrosis. The firm specializes in the development of patient oriented targeted therapy for the treatment of a wide range of fibrotic and inflammatory diseases with high unmet medical need among others. Its therapeutic and diagnostic technology, BC-819, constitutes a search paradigm for the targeted destruction of cancer cells with no effect on surrounding tissue and no observed side effects for long-term, safe treatment and prevention of cancer. The patient oriented targeted therapy approach is based on the identification of particular genes that are expressed only in tumors.

功能特性

資源

市場

收入

資產負債表

現金流量

年度

每季

CMMB 收入

財務數據以百萬美元計。會計年度為二月至一月。

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
營收	0	0	--	0	0	0
營收年增率 (YoY)	--	--	--	--	--	--
營收成本	--	--	3	2	--	--
毛利	--	--	--	-2	--	--
銷售、一般及管理費用	3	3	7	11	6	7
研發	7	11	18	13	6	3
營業費用	10	14	22	25	12	10
其他非營業收入 (費用)	--	--	--	--	--	--
稅前淨利	-10	-13	-24	-28	-12	-11
所得稅費用	0	0	0	0	--	--
淨利	-10	-13	-24	-27	-12	-11
淨利成長	-28.99%	-46%	-11%	125%	9%	-59%
稀釋後流通股數	494.33	89.76	58.74	56.89	3.24	0.57
股數年變動 (YoY)	463.99%	53%	3%	1,655%	459%	8%
每股盈餘 (稀釋)	-0.02	-0.15	-0.41	-0.48	-3.84	-20.02
每股盈餘成長率	-88%	-62%	-14%	-88%	-81%	-60%
自由現金流	--	-15	-23	-20	-12	-5
每股自由現金流	--	--	--	--	--	--
毛利率	--	--	--	0%	--	--
營業利益率	0%	0%	--	0%	0%	0%
淨利率	0%	0%	--	0%	0%	0%
自由現金流利潤率	--	0%	--	0%	0%	0%
EBITDA	--	-14	-25	-28	-12	-10
EBITDA 利潤率	--	0%	--	0%	0%	0%
EBITDA 中的折舊與攤銷	--	0	0	0	0	0
EBIT	-10	-14	-25	-28	-12	-10
EBIT 利潤率	0%	0%	--	0%	0%	0%
有效稅率	0%	0%	0%	0%	--	--

Chemomab Therapeutics Ltd（CMMB）價格

CMMB 股價走勢圖